Pioneering 3D Human Tissues for Drug Discovery

Nov 15 | 2022

Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates

Read More »

Sep 06 | 2022

Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Read More »

Sep 06 | 2022

Organovo Announces Postponement of Annual Meeting of Stockholders

Read More »